ChemBK
Home
Product Category
Suppliers
Search
2,3-Dimethyl-2H-indazol-7-ylamine
Request for Quotation
2H-Indazol-7-amine, 2,3-dimethyl-
CAS: 1783625-55-7
Molecular Formula: C9H11N3
Home
Product Category
Organic raw materials
Heterocyclic compound
2,3-Dimethyl-2H-indazol-7-ylamine
2,3-Dimethyl-2H-indazol-7-ylamine -
Names and Identifiers
Name
2H-Indazol-7-amine, 2,3-dimethyl-
Synonyms
Pazopanib Impurity 39
2,3-Dimethylindazol-7-amine
2,3-dimethyl-2H-Indazol-7-amine
2,3-Dimethyl-2H-indazol-7-ylamine
2H-Indazol-7-amine, 2,3-dimethyl-
CAS
1783625-55-7
2,3-Dimethyl-2H-indazol-7-ylamine -
Physico-chemical Properties
Molecular Formula
C9H11N3
Molar Mass
161.2
Density
1.23±0.1 g/cm3(Predicted)
Boling Point
366.9±22.0 °C(Predicted)
pKa
3.55±0.10(Predicted)
View 2,3-Dimethyl-2H-indazol-7-ylamine structural formula
Supplier List
Hubei YoungXin Pharmaceutical Tech Co.,Ltd.
Spot supply
Product Name:
Pazopanib Impurity 39
Visit Supplier Webpage
Request for quotation
CAS: 1783625-55-7
Tel: 0714-3999186
Email: 2853786052@qq.com
Mobile: 86+15671228036
QQ: 2853786052
Wechat: 15671228036
Shanghai Acmec Biochemical Technology Co., Ltd.
Spot supply
Product Name:
2H-Indazol-7-amine, 2,3-dimethyl-
Visit Supplier Webpage
Request for quotation
CAS: 1783625-55-7
Tel: +86-400-900-4166
Email: product@acmec-e.com
Mobile: +86-18621343501
QQ: 2881950922
Wechat: 19602116810
WhatsApp: +86-18621343501
Hubei YoungXin Pharmaceutical Tech Co.,Ltd.
Spot supply
Product Name:
Pazopanib Impurity 39
Visit Supplier Webpage
Request for quotation
CAS: 1783625-55-7
Tel: 0714-3999186
Email: 2853786052@qq.com
Mobile: 86+15671228036
QQ: 2853786052
Wechat: 15671228036
Shanghai Acmec Biochemical Technology Co., Ltd.
Spot supply
Product Name:
2H-Indazol-7-amine, 2,3-dimethyl-
Visit Supplier Webpage
Request for quotation
CAS: 1783625-55-7
Tel: +86-400-900-4166
Email: product@acmec-e.com
Mobile: +86-18621343501
QQ: 2881950922
Wechat: 19602116810
WhatsApp: +86-18621343501
View History
2,3-Dimethyl-2H-indazol-7-ylamine
Home
Product Category
© 2015, 2023 ChemBK.com All Rights Reserved | Build: 20230617001